Adastra Holdings（XTRX）株式概要アダストラ・ホールディングス・リミテッドは、カナダの娯楽および医療市場向けに大麻の抽出と加工を行っている。 詳細XTRX ファンダメンタル分析スノーフレーク・スコア評価2/6将来の成長0/6過去の実績0/6財務の健全性0/6配当金0/6リスク分析過去5年間で収益は年間20.9%減少しました。 マイナスの株主資本 株式の流動性は非常に低い 意味のある時価総額がありません ( CA$1M )+1 さらなるリスクすべてのリスクチェックを見るXTRX Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.NEW471,327 membersJoin community and earn perksGain real feedbackFrom our editorial team, personally. Not silence.Grow your followingReal investors. The kind who actually invest, not scroll past.Unlock free accessFree premium subscription for consistent and quality authors.Learn moreCreate NarrativeBLINRODA471,327 investors already sharing narrativesYour Fair ValueCA$Current PriceCA$0.2099.3% 割安 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-15m75m2016201920222025202620282031Revenue CA$74.5mEarnings CA$11.1mAdvancedSet Fair ValueView all narrativesAdastra Holdings Ltd. 競合他社Lumiera HealthSymbol: TSXV:NHP.HMarket cap: CA$849.8kOvation ScienceSymbol: CNSX:OVATMarket cap: CA$1.2mRAMM PharmaSymbol: CNSX:RAMMMarket cap: CA$1.2mCanadaBis CapitalSymbol: TSXV:CANBMarket cap: CA$2.1m価格と性能株価の高値、安値、推移の概要Adastra Holdings過去の株価現在の株価CA$0.2052週高値CA$0.8052週安値CA$0.20ベータ-0.511ヶ月の変化0%3ヶ月変化n/a1年変化0%3年間の変化-93.33%5年間の変化-97.87%IPOからの変化-98.61%最新ニュースお知らせ • May 06Adastra Holdings Ltd. Announces Director Changes, Effective April 30, 2026Adastra Holdings Ltd. announced that Calum Maschi has been appointed as a director of the Company in place of Jonathan Edwards who has resigned as a director, effective April 30, 2026. Mr. Maschi is a construction professional with over fifteen years of experience across large scale industrial, institutional and infrastructure projects, including management roles on major projects such as LNG Canada.お知らせ • Oct 16+ 2 more updatesAn undisclosed buyer completed the acquisition of Adastra Labs Holdings (2019) Ltd. from Adastra Holdings Ltd. (CNSX:XTRX).An undisclosed buyer entered into an agreement to acquire Adastra Labs Holdings (2019) Ltd. from Adastra Holdings Ltd. (CNSX:XTRX) for CAD 0.50 million on October 8, 2025. The consideration of CAD 0.495 million is payable by way of a 12% interest-bearing promissory note. In separate transactions, an undisclosed buyer entered into an agreement to acquire 1178562 B.C. Ltd. and Adastra Brands Inc. from Adastra Holdings Ltd. on October 8, 2025. The aggregate consideration for all transactions is CAD 4 million. The sale of Adastra Holdings Ltd.'s subsidiaries aligns with its strategy to strengthen its balance sheet, reduce debt, and streamline operations. The transactions are expected to be completed shortly and remain subject to customary closing conditions. An undisclosed buyer completed the acquisition of Adastra Labs Holdings (2019) Ltd. from Adastra Holdings Ltd. (CNSX:XTRX) on October 15, 2025.お知らせ • Oct 10+ 1 more updateAn undisclosed buyer agreed to acquire Adastra Brands Inc. from Adastra Holdings Ltd. (CNSX:XTRX) for CAD 5000.An undisclosed buyer agreed to acquire Adastra Brands Inc. from Adastra Holdings Ltd. (CNSX:XTRX) for CAD 5000 on October 8, 2025. The consideration of CAD 5000 will be paid in cash. In separate transactions, an undisclosed buyer entered into an agreement to acquire Adastra Labs Holdings (2019) Ltd. and 1178562 B.C. Ltd. from Adastra Holdings Ltd. on October 8, 2025. The aggregate consideration for all transactions is CAD 4 million. The sale of Adastra Holdings Ltd.'s subsidiaries aligns with its strategy to strengthen its balance sheet, reduce debt, and streamline operations. The transactions are expected to be completed shortly and remain subject to customary closing conditions.お知らせ • Sep 26Adastra Holdings Ltd., Annual General Meeting, Nov 19, 2025Adastra Holdings Ltd., Annual General Meeting, Nov 19, 2025.New Risk • Aug 31New major risk - Negative shareholders equityThe company has negative equity. Total equity: -CA$315k This is considered a major risk. Being in negative equity means that the company's liabilities exceed its assets, meaning it owes more to creditors than it has in owned assets. While this doesn't mean the company is about to collapse, in the long-term, this is unsustainable. The company may have issues meeting financial obligations, is at risk of becoming insolvent and may have difficulty raising capital, especially more debt, if needed. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Negative equity (-CA$315k). Earnings have declined by 13% per year over the past 5 years. Market cap is less than US$10m (CA$1.40m market cap, or US$1.02m).Reported Earnings • Aug 31Second quarter 2025 earnings released: CA$0.19 loss per share (vs CA$0.014 profit in 2Q 2024)Second quarter 2025 results: CA$0.19 loss per share (down from CA$0.014 profit in 2Q 2024). Revenue: CA$2.91m (down 58% from 2Q 2024). Net loss: CA$1.08m (down CA$1.16m from profit in 2Q 2024).最新情報をもっと見るRecent updatesお知らせ • May 06Adastra Holdings Ltd. Announces Director Changes, Effective April 30, 2026Adastra Holdings Ltd. announced that Calum Maschi has been appointed as a director of the Company in place of Jonathan Edwards who has resigned as a director, effective April 30, 2026. Mr. Maschi is a construction professional with over fifteen years of experience across large scale industrial, institutional and infrastructure projects, including management roles on major projects such as LNG Canada.お知らせ • Oct 16+ 2 more updatesAn undisclosed buyer completed the acquisition of Adastra Labs Holdings (2019) Ltd. from Adastra Holdings Ltd. (CNSX:XTRX).An undisclosed buyer entered into an agreement to acquire Adastra Labs Holdings (2019) Ltd. from Adastra Holdings Ltd. (CNSX:XTRX) for CAD 0.50 million on October 8, 2025. The consideration of CAD 0.495 million is payable by way of a 12% interest-bearing promissory note. In separate transactions, an undisclosed buyer entered into an agreement to acquire 1178562 B.C. Ltd. and Adastra Brands Inc. from Adastra Holdings Ltd. on October 8, 2025. The aggregate consideration for all transactions is CAD 4 million. The sale of Adastra Holdings Ltd.'s subsidiaries aligns with its strategy to strengthen its balance sheet, reduce debt, and streamline operations. The transactions are expected to be completed shortly and remain subject to customary closing conditions. An undisclosed buyer completed the acquisition of Adastra Labs Holdings (2019) Ltd. from Adastra Holdings Ltd. (CNSX:XTRX) on October 15, 2025.お知らせ • Oct 10+ 1 more updateAn undisclosed buyer agreed to acquire Adastra Brands Inc. from Adastra Holdings Ltd. (CNSX:XTRX) for CAD 5000.An undisclosed buyer agreed to acquire Adastra Brands Inc. from Adastra Holdings Ltd. (CNSX:XTRX) for CAD 5000 on October 8, 2025. The consideration of CAD 5000 will be paid in cash. In separate transactions, an undisclosed buyer entered into an agreement to acquire Adastra Labs Holdings (2019) Ltd. and 1178562 B.C. Ltd. from Adastra Holdings Ltd. on October 8, 2025. The aggregate consideration for all transactions is CAD 4 million. The sale of Adastra Holdings Ltd.'s subsidiaries aligns with its strategy to strengthen its balance sheet, reduce debt, and streamline operations. The transactions are expected to be completed shortly and remain subject to customary closing conditions.お知らせ • Sep 26Adastra Holdings Ltd., Annual General Meeting, Nov 19, 2025Adastra Holdings Ltd., Annual General Meeting, Nov 19, 2025.New Risk • Aug 31New major risk - Negative shareholders equityThe company has negative equity. Total equity: -CA$315k This is considered a major risk. Being in negative equity means that the company's liabilities exceed its assets, meaning it owes more to creditors than it has in owned assets. While this doesn't mean the company is about to collapse, in the long-term, this is unsustainable. The company may have issues meeting financial obligations, is at risk of becoming insolvent and may have difficulty raising capital, especially more debt, if needed. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Negative equity (-CA$315k). Earnings have declined by 13% per year over the past 5 years. Market cap is less than US$10m (CA$1.40m market cap, or US$1.02m).Reported Earnings • Aug 31Second quarter 2025 earnings released: CA$0.19 loss per share (vs CA$0.014 profit in 2Q 2024)Second quarter 2025 results: CA$0.19 loss per share (down from CA$0.014 profit in 2Q 2024). Revenue: CA$2.91m (down 58% from 2Q 2024). Net loss: CA$1.08m (down CA$1.16m from profit in 2Q 2024).New Risk • Jun 02New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -CA$93k This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CA$93k free cash flow). Shares are highly illiquid. Earnings have declined by 3.4% per year over the past 5 years. Market cap is less than US$10m (CA$1.34m market cap, or US$978.9k).Reported Earnings • Jun 02First quarter 2025 earnings released: CA$0.12 loss per share (vs CA$0.23 loss in 1Q 2024)First quarter 2025 results: CA$0.12 loss per share (improved from CA$0.23 loss in 1Q 2024). Revenue: CA$4.47m (down 32% from 1Q 2024). Net loss: CA$684.9k (loss narrowed 48% from 1Q 2024).分析記事 • Mar 27Adastra Holdings Ltd. (CSE:XTRX) Soars 40% But It's A Story Of Risk Vs RewardDespite an already strong run, Adastra Holdings Ltd. ( CSE:XTRX ) shares have been powering on, with a gain of 40% in...お知らせ • Feb 04Adastra Holdings Ltd. Announces Resignation of Andrew Hale as A Director, Effective February 14, 2025Adastra Holdings Ltd. announced that Andrew Hale has tendered his resignation as a director of the Company effective as of February 14, 2025. The Company thanks Mr. Hale for his service as a member of the board of directors. The remaining directors are in the process of identifying a candidate to fill the pending vacancy and will provide an update once available.Reported Earnings • Dec 01Third quarter 2024 earnings released: EPS: CA$0.002 (vs CA$0.12 loss in 3Q 2023)Third quarter 2024 results: EPS: CA$0.002 (up from CA$0.12 loss in 3Q 2023). Revenue: CA$7.10m (up 63% from 3Q 2023). Net income: CA$84.5k (up CA$726.7k from 3Q 2023). Profit margin: 1.2% (up from net loss in 3Q 2023).分析記事 • Oct 23Market Cool On Adastra Holdings Ltd.'s (CSE:XTRX) Revenues Pushing Shares 26% LowerThe Adastra Holdings Ltd. ( CSE:XTRX ) share price has fared very poorly over the last month, falling by a substantial...お知らせ • Oct 18Adastra Holdings Ltd., Annual General Meeting, Dec 13, 2024Adastra Holdings Ltd., Annual General Meeting, Dec 13, 2024.お知らせ • Sep 26+ 2 more updatesLachlan Mcleod Resigns as Chief Financial Officer of Adastra Holdings LtdAdastra Holdings Ltd. announced that Lachlan McLeod, Chief Financial Officer, has resigned from his role. Mr. McLeod's will remain in his roles as CFO until November 25, 2024, to ensure a smooth transition and maintain continuity as the Company moves forward. The Company is currently in the process of selecting and approving new candidates to fill these roles.分析記事 • Sep 08Market Cool On Adastra Holdings Ltd.'s (CSE:XTRX) Revenues Pushing Shares 26% LowerTo the annoyance of some shareholders, Adastra Holdings Ltd. ( CSE:XTRX ) shares are down a considerable 26% in the...分析記事 • Sep 04Is Adastra Holdings (CSE:XTRX) A Risky Investment?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Reported Earnings • Sep 01Second quarter 2024 earnings released: EPS: CA$0.001 (vs CA$0.019 loss in 2Q 2023)Second quarter 2024 results: EPS: CA$0.001 (up from CA$0.019 loss in 2Q 2023). Revenue: CA$6.87m (down 3.2% from 2Q 2023). Net income: CA$80.9k (up CA$1.15m from 2Q 2023). Profit margin: 1.2% (up from net loss in 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has fallen by 56% per year, which means it is performing significantly worse than earnings.分析記事 • Jul 11Adastra Holdings Ltd. (CSE:XTRX) Might Not Be As Mispriced As It Looks After Plunging 41%Unfortunately for some shareholders, the Adastra Holdings Ltd. ( CSE:XTRX ) share price has dived 41% in the last...Reported Earnings • Jun 04First quarter 2024 earnings released: CA$0.023 loss per share (vs CA$0.006 loss in 1Q 2023)First quarter 2024 results: CA$0.023 loss per share (further deteriorated from CA$0.006 loss in 1Q 2023). Revenue: CA$6.53m (up 13% from 1Q 2023). Net loss: CA$1.31m (loss widened 325% from 1Q 2023). Over the last 3 years on average, earnings per share has increased by 1% per year but the company’s share price has fallen by 42% per year, which means it is significantly lagging earnings.分析記事 • May 08Adastra Holdings Ltd. (CSE:XTRX) Might Not Be As Mispriced As It Looks After Plunging 27%Adastra Holdings Ltd. ( CSE:XTRX ) shareholders won't be pleased to see that the share price has had a very rough...お知らせ • May 03Adastra Holdings Files Form 15Adastra Holdings Ltd. has announced that it has filed a Form 15 with the Securities and Exchange Commission to voluntarily deregister its common shares under the Securities Exchange Act of 1934, as amended.Reported Earnings • Apr 24Full year 2023 earnings released: CA$0.063 loss per share (vs CA$0.072 loss in FY 2022)Full year 2023 results: CA$0.063 loss per share (improved from CA$0.072 loss in FY 2022). Revenue: CA$22.2m (up 67% from FY 2022). Net loss: CA$3.54m (loss narrowed 17% from FY 2022). Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has fallen by 41% per year, which means it is significantly lagging earnings.Board Change • Apr 19Less than half of directors are independentThere are 3 new directors who have joined the board in the last 3 years. Of these new board members, 1 was an independent director. The company's board is composed of: 3 new directors. No experienced directors. No highly experienced directors. 1 independent director (2 non-independent directors). Independent Director Paul Morgan is the most experienced director on the board, commencing their role in 2021. They were also the last independent director to join the board. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of experienced directors.お知らせ • Apr 16+ 1 more updateAdastra Holdings Ltd. Announces Resignation of Smoke Wallin from Its Board of DirectorsAdastra Holdings Ltd. announced the resignation of Smoke Wallin from its Board of Directors, effective April 12, 2024. Mr. Wallin, who has served as a Director on Adastra's Board since May 2022, will be focusing on his other business ventures. The Company is now in the process of selecting a new Director to fill the Board vacancy.お知らせ • Apr 03Adastra Holdings Announces Executive ChangesAdastra Holdings Ltd. announced the appointment of Jon Edwards to its Board of Directors, effective April 2, 2024. With over 15 years of experience, Mr. Edwards has held various positions within the B.C. Public Service, specializing in interpreting and applying legislation for the Ministry of Justice and Housing. He holds a Bachelor of Arts in Justice Studies and a Master of Arts in Conflict Analysis and Management, both from Royal Roads University. Mr. Edwards will use his extensive experience and commitment to excellence to positively impact the Company towards continued success. Mr. Edwards will be replacing Michael Forbes on Adastra's Board of Directors. On March 29, 2024, Mr. Forbes resigned as CEO, Director and Corporate Secretary, as previously announced in a news release dated March 1, 2024. Adastra also announces that Lachlan McLeod, the Company's CFO, has been appointed Corporate Secretary, effective April 2, 2024, while maintaining his current duties as CFO.Board Change • Apr 01High number of new directorsDirector Andy Hale was the last director to join the board, commencing their role in 2024.分析記事 • Mar 08Adastra Holdings Ltd.'s (CSE:XTRX) Shares Leap 26% Yet They're Still Not Telling The Full StoryAdastra Holdings Ltd. ( CSE:XTRX ) shareholders would be excited to see that the share price has had a great month...分析記事 • Jan 23Adastra Holdings Ltd.'s (CSE:XTRX) Shares Not Telling The Full StoryWith a median price-to-sales (or "P/S") ratio of close to 1x in the Pharmaceuticals industry in Canada, you could be...Reported Earnings • Dec 01Third quarter 2023 earnings released: CA$0.011 loss per share (vs CA$0.008 loss in 3Q 2022)Third quarter 2023 results: CA$0.011 loss per share (further deteriorated from CA$0.008 loss in 3Q 2022). Revenue: CA$4.35m (up 14% from 3Q 2022). Net loss: CA$642.2k (loss widened 40% from 3Q 2022). Over the last 3 years on average, earnings per share has increased by 43% per year but the company’s share price has fallen by 40% per year, which means it is significantly lagging earnings.分析記事 • Sep 28Here's Why Adastra Holdings (CSE:XTRX) Can Afford Some DebtLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Reported Earnings • Aug 18Second quarter 2023 earnings released: CA$0.019 loss per share (vs CA$0.008 loss in 2Q 2022)Second quarter 2023 results: CA$0.019 loss per share (further deteriorated from CA$0.008 loss in 2Q 2022). Revenue: CA$7.10m (up 133% from 2Q 2022). Net loss: CA$1.07m (loss widened 124% from 2Q 2022). Over the last 3 years on average, earnings per share has increased by 51% per year but the company’s share price has fallen by 54% per year, which means it is significantly lagging earnings.分析記事 • Aug 03Subdued Growth No Barrier To Adastra Holdings Ltd.'s (CSE:XTRX) PriceIt's not a stretch to say that Adastra Holdings Ltd.'s ( CSE:XTRX ) price-to-sales (or "P/S") ratio of 1.1x right now...お知らせ • Jul 08Adastra Holdings Ltd., Annual General Meeting, Sep 14, 2023Adastra Holdings Ltd., Annual General Meeting, Sep 14, 2023. Location: 900 - 885 West Georgia Street Vancouver British Columbia CanadaReported Earnings • May 03Full year 2022 earnings released: CA$0.072 loss per share (vs CA$0.055 loss in FY 2021)Full year 2022 results: CA$0.072 loss per share (further deteriorated from CA$0.055 loss in FY 2021). Revenue: CA$13.3m (up 136% from FY 2021). Net loss: CA$4.28m (loss widened 56% from FY 2021). Over the last 3 years on average, earnings per share has increased by 51% per year but the company’s share price has fallen by 23% per year, which means it is significantly lagging earnings.お知らせ • Feb 15Adastra Holdings Ltd. Announces Executive ChangesAdastra Holdings Ltd. announced that Lachlan McLeod, CPA of Fehr & Associates, has been appointed Chief Financial Officer. Lachlan has experience in public practice, having worked as an auditor for a Big 4 accounting firm for four years, and has served as a fractional CFO for multiple public companies. Lachlan has a proven track record of helping businesses meet financial and regulatory reporting requirements. Lachlan is a Chartered Professional Accountant (CPA) with a Bachelor's degree in Science with an Economics major and a Business minor from the University of Victoria, and a Diploma of Accounting from the Sauder School of Business at the University of British Columbia. Lachlan replaces Oliver Foeste who will remain with Adastra in an advisory capacity to provide transitional support. The Company thanks Oliver for his services.分析記事 • Jan 13Does Adastra Holdings (CSE:XTRX) Have A Healthy Balance Sheet?The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Reported Earnings • Dec 01Third quarter 2022 earnings released: CA$0.008 loss per share (vs CA$0.005 loss in 3Q 2021)Third quarter 2022 results: CA$0.008 loss per share (further deteriorated from CA$0.005 loss in 3Q 2021). Revenue: CA$3.80m (up 110% from 3Q 2021). Net loss: CA$459.3k (loss widened 121% from 3Q 2021).Board Change • Nov 16High number of new and inexperienced directorsThere are 3 new directors who have joined the board in the last 3 years. The company's board is composed of: 3 new directors. No experienced directors. No highly experienced directors. President, CEO, Chairman & Company Secretary Michael Forbes is the most experienced director on the board, commencing their role in 2021. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model.分析記事 • Sep 28We Think Adastra Holdings (CSE:XTRX) Has A Fair Chunk Of DebtHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...お知らせ • Sep 01Adastra Holdings Ltd. Receives Controlled Substances Dealer's LicenseAdastra Holdings Ltd. announce that the Company received its Controlled Drug and Substances Dealer's License on August 24, 2022. This license allows Adastra to process psilocybin and psilocin, the active compounds derived from psychedelic mushrooms. Under the Dealer's License, Adastra can possess up to 1,000 grams of psilocybin and psilocin at any time and can transfer the extracted material to other companies who hold a valid Dealer's License. Adastra intends to utilize its in-house analytical testing lab, Chemia Analytics, to validate and develop its extraction processes, to optimize and enhance efficiency ahead of any future potential regulatory modifications to the existing psychedelics framework. As the market matures to include regulations for other compounds, such as MDMA, LSD, 5-MeO-DMT and Ketamine, Adastra plans to include these substances in future Dealer's License amendments, positioning itself to leverage clinic and patient demand. When approved, the Company will be permitted to process and formulate a variety of psychedelic compounds, increasingly used and sought-after by patients and healthcare practitioners to combat a variety of physical and mental ailments.Reported Earnings • Aug 27Second quarter 2022 earnings released: CA$0.008 loss per share (vs CA$0.012 loss in 2Q 2021)Second quarter 2022 results: CA$0.008 loss per share (up from CA$0.012 loss in 2Q 2021). Revenue: CA$3.05m (up 146% from 2Q 2021). Net loss: CA$478.1k (loss narrowed 6.2% from 2Q 2021).お知らせ • Aug 18Adastra Holdings Ltd. Receives Its Medical Sales License from Health CanadaAdastra Holdings Ltd. announced it has received its Medical Sales License from Health Canada which now authorizes Adastra to sell cannabinoid-containing products that are formulated for and distributed to the medical cannabis market. With its Medical Sales License, Adastra is now authorized to: Sell cannabis extracts and dried cannabis to medical cannabis patients and licensed health practitioners; and Develop a broad range of products classified as cannabis extracts including: Inhaled, Ingested, and Other Adastra's Medical Sales License will enable the Company to maximize the full potential of PerceiveMD, Adastra's wholly-owned platform, that assesses patients seeking alternative treatments and remedies and provides documentation to enable access. The global medical cannabis market is projected to grow to $248.42 Billion by 2030 at a 31.97% CAGR according to a recent report by Market Research. Adastra expects to start producing medical format cannabis products, specifically CBD tinctures by January 2023. The Company is currently exploring medical distribution platforms for Canadian sales and plans toformulate products based on recommendations from practitioners and patients in its establishednetwork.Board Change • Aug 03High number of new and inexperienced directorsThere are 3 new directors who have joined the board in the last 3 years. The company's board is composed of: 3 new directors. No experienced directors. No highly experienced directors. President, CEO, Chairman & Company Secretary Michael Forbes is the most experienced director on the board, commencing their role in 2021. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model.お知らせ • May 17Adastra Holdings Ltd. Announces the Appointment of Smoke Wallin to the Company's Board of DirectorsAdastra Holdings Ltd. announced the appointment of Smoke Wallin to the Company's board of directors. Mr. Wallin is a highly accomplished CEO, entrepreneur, leader, board member and philanthropist with more than 25 years of success across the consumer products, beverage, cannabis, distribution and technology industries. He is a partner and Managing Director for STS Capital Partners; has frequently served as CEO for new and existing businesses.お知らせ • May 04Adastra Holdings Ltd. announced delayed 20-F filingOn 05/03/2022, Adastra Holdings Ltd. announced that they will be unable to file their next 20-F by the deadline required by the SEC.Board Change • Apr 27High number of new and inexperienced directorsThere are 3 new directors who have joined the board in the last 3 years. The company's board is composed of: 3 new directors. No experienced directors. No highly experienced directors. Independent Director Georges Routhier is the most experienced director on the board, commencing their role in 2019. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model.お知らせ • Apr 22Adastra Holdings Ltd., Annual General Meeting, Jun 23, 2022Adastra Holdings Ltd., Annual General Meeting, Jun 23, 2022. Location: 5451 275 street Langley British Columbia Canadaお知らせ • Apr 08Adastra Announces Successful Soft Launch of Endgame Brand in BCAdastra Holdings Ltd. is excited to announce that its newly developed brand, Endgame, which was soft-launched last week, sold out in less than 24 hours of delivery to the British Columbia Liquor Distribution Branch. Endgame's initial SKU delivery included two varieties of vaporizer cartridges: Mosa x Blood Orange and White Rhino x Raspberry Lemon. In early April, Adastra plans to deliver two new Endgame shatter products to the BCLDB: BlackCherry Punch x Jack Herer and Jack Herer x White Rhino. These hydrocarbon extracted cannabis concentrates are gaining popularity in the Canadian cannabis market for their full spectrum extract potency and flavour.お知らせ • Mar 30Adastra Holdings Ltd. Announces Executive ChangesAdastra Holdings Ltd. announced update to its leadership structure with the departure of Chief Operating Officer, Corporate Secretary and Director, Donald Dinsmore, and the appointment of Michael Forbes as Corporate Secretary.分析記事 • Mar 23Does Adastra Holdings (CSE:XTRX) Have A Healthy Balance Sheet?The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...分析記事 • Dec 07Here's Why Adastra Holdings (CSE:XTRX) Can Afford Some DebtHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Board Change • Dec 06High number of new and inexperienced directorsThere are 4 new directors who have joined the board in the last 3 years. The company's board is composed of: 4 new directors. No experienced directors. No highly experienced directors. Independent Director Georges Routhier is the most experienced director on the board, commencing their role in 2019. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model.Recent Insider Transactions • Sep 04President recently bought CA$1.1m worth of stockOn the 31st of August, Michael Forbes bought around 1m shares on-market at roughly CA$0.91 per share. This was the largest purchase by an insider in the last 3 months. This was Michael's only on-market trade for the last 12 months.分析記事 • Aug 18Here's Why Phyto Extractions (CSE:XTRX) Can Afford Some DebtSome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...お知らせ • Jun 03Phyto Extractions Inc. Officially Launches Shatter for Adult-Use MarketPhyto Extractions Inc. strives to continuously bring consumers new and innovative products to enhance their experience and overall enjoyment. Shatter is Phyto ExtractionsTM newest product category, with three new high THC extract offerings produced from single- source strains (local to BC and ON). Available in three highly popular strains including: Blue Gorilla OG, Pink Kush and D Bubba, all Phyto ExtractionsTM shatter is extracted and processed in a controlled laboratory environment to prevent contaminants, living up to the brands promise of offering consumers products that are free of additives and synthetic fillers. In partnership with Namaste Technologies Inc. subsidiary, CannMart Inc., Phyto ExtractionsTM shatter is now available through licensed adult-use retailers in British Columbia, Saskatchewan and Manitoba. Strain availability currently varies in each provincial distributor and private store. Pink Kush and D Bubba have been selected in British Columbia. All three SKUs; Blue Gorilla OG, D Bubba and Pink Kush are available in Saskatchewan and Manitoba.分析記事 • May 04Auditors Have Doubts About Phyto Extractions (CSE:XTRX)Unfortunately for shareholders, when Phyto Extractions Inc. ( CSE:XTRX ) reported results for the period to December...お知らせ • Mar 25Adastra Labs Holdings Ltd. announced a financing transactionAdastra Labs Holdings Ltd. (CNSX:XTRX) announced a private placement on best effort basis of equity units at a price of CAD 1.10 per unit on March 23, 2021. The transaction will include participation from qualified investors, mainly accredited investors. Each unit consists of one common share and one warrant exercisable at CAD 1.75 per share for a period of 24 months from date of issuance. The warrants are subject to acceleration in the event the company’s common shares trade at or above CAD 2 per share for more than 50 trading days. The transaction will close in one or more tranches.お知らせ • Mar 12+ 1 more updateAdastra Labs Holdings (2019) Ltd. Announces Executive ChangesAdastra Labs Holdings (2019) Ltd. announced the appointment of J. Scott Munro as CEO effective March 1, 2021 in conjunction with the resignation and retirement of Andy Hale from said positions. J. Scott Munro is an experienced venture capitalist, accountant and entrepreneur who has led companies and served in a variety of senior executive roles including CEO, CFO and director in both Canadian and U.S. public and private companies for over 25 years. Over the past 10+ years, Scott has owned and operated private venture capital and consulting firms that provide M&A advisory, going-public transactions, reporting, and other services to private and public companies, including in the Life Sciences sector in which Adastra operates.Is New 90 Day High Low • Feb 03New 90-day low: CA$0.33The company is down 38% from its price of CA$0.53 on 04 November 2020. The Canadian market is up 14% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Pharmaceuticals industry, which is up 70% over the same period.分析記事 • Dec 10Adastra Labs Holdings (CSE:XTRX) Is Making Moderate Use Of DebtThe external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Is New 90 Day High Low • Nov 17New 90-day low: CA$0.48The company is down 44% from its price of CA$0.86 on 19 August 2020. The Canadian market is up 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Pharmaceuticals industry, which is up 18% over the same period.お知らせ • Nov 14Adastra Labs Holdings Ltd. Commences Full-Scale Cryo-Ethanol Extraction OperationsAdastra Labs Holdings Ltd. announced the full-scale operation of its cryo-ethanol extraction system from Evolved Extraction Solutions (Evolved). The Evolved team integrated with the Adastra production workforce to commission the EV-MASS system while leveraging remote support from the Yellowstone Falling Film Evaporator operations team. Both the EV-MASS cryo-ethanol system and the Yellowstone high-volume ethanol recovery system met all operational targets for the commissioning. The high quality cannabis oil has produced superior high potency cannabis THC distillate after follow-on processing with the company’s molecular wiped-film distillation systems. The EV-MASS cryo-ethanol system has commenced full operational capability after processing several hundred kilograms of cannabis biomass in a fraction of the time required by other extraction systems. The commissioning validated the ability of the system to process 650 KG of cannabis or hemp biomass per day, has made the company’s CO2 extraction line available for other concentrate products and reduced substantially the time required to produce cannabis oils and THC distillate. The industrial-scale EV-MASS system has become fully operation just in time to exploit the large processing demand the first outdoor Canadian cannabis harvest brings.Is New 90 Day High Low • Oct 19New 90-day low: CA$0.67The company is down 14% from its price of CA$0.78 on 21 July 2020. The Canadian market is up 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Pharmaceuticals industry, which is up 7.0% over the same period.お知らせ • Oct 04Adastra Labs Holdings Ltd. Announces the Completion of Installation and Start of Commissioning of its Cryo-Ethanol Extraction System from Evolved Extraction SolutionsAdastra Labs Holdings Ltd. announced the completion of installation and start of commissioning of its cryo-ethanol extraction system from Evolved Extraction Solutions ("Evolved"). The Evolved team provided equipment and installation services along with support from the Yellowstone Falling Film Evaporator OEM. The combination of the EV-MASS cryo-ethanol system with the high-volume ethanol recovery unit from Yellowstone substantially reduces the time to produce large volumes of cannabis oil ready for molecular distillation into high potency THC distillate. Commissioning and training services for the EV-MASS cryo-ethanol system has commenced with full operational capability planned in the coming weeks to ensure the EV-MASS system meets performance requirements. The cryo-ethanol extraction system is capable of processing 650 KG of cannabis or hemp biomass per day, producing winterized (de-waxed) cannabis or hemp oil. The EV-MASS integrated solution provides an optimized process flow that is expected to reduce the costs of production. The modular design permits Adastra to easily scale up capacity with simplified installation in the event of increased market demand. Further, the cryo-ethanol system frees up Adastra's CO2 extraction line for other types of concentrate products and will reduce the time required to produce cannabis oil as it comes online.Is New 90 Day High Low • Sep 19New 90-day high: CA$0.98The company is up 206% from its price of CA$0.32 on 19 June 2020. The Canadian market is up 7.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Pharmaceuticals industry, which is up 3.0% over the same period.お知らせ • Jul 17Adastra Labs Holdings Ltd. announced that it has received CAD 3.4944 million in fundingOn July 14, 2020, Adastra Labs Holdings Ltd. (CNSX:XTRX) closed the transaction. The company issued 11,648,001 units for gross proceeds of CAD 3,494,400.3. The company paid finders fees of CAD 21,600 in cash and 72,000 compensation options to Ascenta Finance Corp. in relation to the transaction. Each compensation warrant shall entitle the holder to purchase one unit for a period of 24 months from the closing of the transaction on the same terms as that of the warrants issued in the transaction. The transaction has been oversubscribed.お知らせ • Jul 05Adastra Labs Holdings Ltd. to Report Second Half, 2020 Results on Jul 14, 2020Adastra Labs Holdings Ltd. announced that they will report second half, 2020 results on Jul 14, 2020お知らせ • Jun 19+ 1 more updateAdastra Labs Holdings Ltd. announced that it expects to receive CAD 1 million in fundingAdastra Labs Holdings Ltd. (CNSX:XTRX) announced non-brokered private placement of up to 3,333,333 units at a price of CAD 0.30 per unit for gross proceeds of up to CAD 1,000,000 on June 18, 2020. Each unit consists of one common share and one common share purchase warrant exercisable at CAD 0.50 per share for a period of 24 months from issue. The warrants are subject to acceleration to the date that is 30 days after the date of notice of company if closing price exceeds CAD 0.70 per share for 10 consecutive trading days. The units to be issued will be subject to a four month and one day hold period. The company may close the transaction in one or more tranches. The company may pay commissions or finder fees. The company may make over allotments till CAD 2,000,000. The transaction is subject to applicable securities laws and regulatory approval.株主還元XTRXCA PharmaceuticalsCA 市場7D0%-0.7%2.0%1Y0%11.9%29.8%株主還元を見る業界別リターン: XTRX過去 1 年間で11.9 % の収益を上げたCanadian Pharmaceuticals業界を下回りました。リターン対市場: XTRXは、過去 1 年間で29.8 % のリターンを上げたCanadian市場を下回りました。価格変動Is XTRX's price volatile compared to industry and market?XTRX volatilityXTRX Average Weekly Movementn/aPharmaceuticals Industry Average Movement8.4%Market Average Movement9.7%10% most volatile stocks in CA Market16.3%10% least volatile stocks in CA Market3.7%安定した株価: XTRXの株価は、 Canadian市場と比較して過去 3 か月間で変動しています。時間の経過による変動: 過去 1 年間のXTRXのボラティリティの変化を判断するには データが不十分です。会社概要設立従業員CEO（最高経営責任者ウェブサイトn/an/an/aadastraholdings.caAdastra Holdings Ltd.は、カナダの娯楽および医療市場向けに大麻の抽出と加工を行っている。同社はEndgameブランド名でVAPEペン、ワックス、レジン、インフューズド・プリロール、ダイヤモンド、シャターを提供している。また、コンサルティング、ホワイトラベル製造、トーリングサービス、消費者向けパッケージ商品販売のための知的財産のライセンスも提供している。同社は以前はPhyto Extraction Inc.として知られていたが、2021年9月にAdastra Holdings Ltd.に社名を変更した。アダストラ・ホールディングス・リミテッドはカナダのラングレーに本社を置いている。もっと見るAdastra Holdings Ltd. 基礎のまとめAdastra Holdings の収益と売上を時価総額と比較するとどうか。XTRX 基礎統計学時価総額CA$1.12m収益（TTM）-CA$14.49m売上高(TTM)CA$16.86m0.1xP/Sレシオ-0.1xPER（株価収益率XTRX は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計XTRX 損益計算書（TTM）収益CA$16.86m売上原価CA$11.36m売上総利益CA$5.51mその他の費用CA$19.99m収益-CA$14.49m直近の収益報告Sep 30, 2025次回決算日該当なし一株当たり利益（EPS）-2.59グロス・マージン32.66%純利益率-85.92%有利子負債／自己資本比率-374.4%XTRX の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/08/06 08:30終値2026/05/12 00:00収益2025/09/30年間収益2024/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Adastra Holdings Ltd. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • May 06Adastra Holdings Ltd. Announces Director Changes, Effective April 30, 2026Adastra Holdings Ltd. announced that Calum Maschi has been appointed as a director of the Company in place of Jonathan Edwards who has resigned as a director, effective April 30, 2026. Mr. Maschi is a construction professional with over fifteen years of experience across large scale industrial, institutional and infrastructure projects, including management roles on major projects such as LNG Canada.
お知らせ • Oct 16+ 2 more updatesAn undisclosed buyer completed the acquisition of Adastra Labs Holdings (2019) Ltd. from Adastra Holdings Ltd. (CNSX:XTRX).An undisclosed buyer entered into an agreement to acquire Adastra Labs Holdings (2019) Ltd. from Adastra Holdings Ltd. (CNSX:XTRX) for CAD 0.50 million on October 8, 2025. The consideration of CAD 0.495 million is payable by way of a 12% interest-bearing promissory note. In separate transactions, an undisclosed buyer entered into an agreement to acquire 1178562 B.C. Ltd. and Adastra Brands Inc. from Adastra Holdings Ltd. on October 8, 2025. The aggregate consideration for all transactions is CAD 4 million. The sale of Adastra Holdings Ltd.'s subsidiaries aligns with its strategy to strengthen its balance sheet, reduce debt, and streamline operations. The transactions are expected to be completed shortly and remain subject to customary closing conditions. An undisclosed buyer completed the acquisition of Adastra Labs Holdings (2019) Ltd. from Adastra Holdings Ltd. (CNSX:XTRX) on October 15, 2025.
お知らせ • Oct 10+ 1 more updateAn undisclosed buyer agreed to acquire Adastra Brands Inc. from Adastra Holdings Ltd. (CNSX:XTRX) for CAD 5000.An undisclosed buyer agreed to acquire Adastra Brands Inc. from Adastra Holdings Ltd. (CNSX:XTRX) for CAD 5000 on October 8, 2025. The consideration of CAD 5000 will be paid in cash. In separate transactions, an undisclosed buyer entered into an agreement to acquire Adastra Labs Holdings (2019) Ltd. and 1178562 B.C. Ltd. from Adastra Holdings Ltd. on October 8, 2025. The aggregate consideration for all transactions is CAD 4 million. The sale of Adastra Holdings Ltd.'s subsidiaries aligns with its strategy to strengthen its balance sheet, reduce debt, and streamline operations. The transactions are expected to be completed shortly and remain subject to customary closing conditions.
お知らせ • Sep 26Adastra Holdings Ltd., Annual General Meeting, Nov 19, 2025Adastra Holdings Ltd., Annual General Meeting, Nov 19, 2025.
New Risk • Aug 31New major risk - Negative shareholders equityThe company has negative equity. Total equity: -CA$315k This is considered a major risk. Being in negative equity means that the company's liabilities exceed its assets, meaning it owes more to creditors than it has in owned assets. While this doesn't mean the company is about to collapse, in the long-term, this is unsustainable. The company may have issues meeting financial obligations, is at risk of becoming insolvent and may have difficulty raising capital, especially more debt, if needed. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Negative equity (-CA$315k). Earnings have declined by 13% per year over the past 5 years. Market cap is less than US$10m (CA$1.40m market cap, or US$1.02m).
Reported Earnings • Aug 31Second quarter 2025 earnings released: CA$0.19 loss per share (vs CA$0.014 profit in 2Q 2024)Second quarter 2025 results: CA$0.19 loss per share (down from CA$0.014 profit in 2Q 2024). Revenue: CA$2.91m (down 58% from 2Q 2024). Net loss: CA$1.08m (down CA$1.16m from profit in 2Q 2024).
お知らせ • May 06Adastra Holdings Ltd. Announces Director Changes, Effective April 30, 2026Adastra Holdings Ltd. announced that Calum Maschi has been appointed as a director of the Company in place of Jonathan Edwards who has resigned as a director, effective April 30, 2026. Mr. Maschi is a construction professional with over fifteen years of experience across large scale industrial, institutional and infrastructure projects, including management roles on major projects such as LNG Canada.
お知らせ • Oct 16+ 2 more updatesAn undisclosed buyer completed the acquisition of Adastra Labs Holdings (2019) Ltd. from Adastra Holdings Ltd. (CNSX:XTRX).An undisclosed buyer entered into an agreement to acquire Adastra Labs Holdings (2019) Ltd. from Adastra Holdings Ltd. (CNSX:XTRX) for CAD 0.50 million on October 8, 2025. The consideration of CAD 0.495 million is payable by way of a 12% interest-bearing promissory note. In separate transactions, an undisclosed buyer entered into an agreement to acquire 1178562 B.C. Ltd. and Adastra Brands Inc. from Adastra Holdings Ltd. on October 8, 2025. The aggregate consideration for all transactions is CAD 4 million. The sale of Adastra Holdings Ltd.'s subsidiaries aligns with its strategy to strengthen its balance sheet, reduce debt, and streamline operations. The transactions are expected to be completed shortly and remain subject to customary closing conditions. An undisclosed buyer completed the acquisition of Adastra Labs Holdings (2019) Ltd. from Adastra Holdings Ltd. (CNSX:XTRX) on October 15, 2025.
お知らせ • Oct 10+ 1 more updateAn undisclosed buyer agreed to acquire Adastra Brands Inc. from Adastra Holdings Ltd. (CNSX:XTRX) for CAD 5000.An undisclosed buyer agreed to acquire Adastra Brands Inc. from Adastra Holdings Ltd. (CNSX:XTRX) for CAD 5000 on October 8, 2025. The consideration of CAD 5000 will be paid in cash. In separate transactions, an undisclosed buyer entered into an agreement to acquire Adastra Labs Holdings (2019) Ltd. and 1178562 B.C. Ltd. from Adastra Holdings Ltd. on October 8, 2025. The aggregate consideration for all transactions is CAD 4 million. The sale of Adastra Holdings Ltd.'s subsidiaries aligns with its strategy to strengthen its balance sheet, reduce debt, and streamline operations. The transactions are expected to be completed shortly and remain subject to customary closing conditions.
お知らせ • Sep 26Adastra Holdings Ltd., Annual General Meeting, Nov 19, 2025Adastra Holdings Ltd., Annual General Meeting, Nov 19, 2025.
New Risk • Aug 31New major risk - Negative shareholders equityThe company has negative equity. Total equity: -CA$315k This is considered a major risk. Being in negative equity means that the company's liabilities exceed its assets, meaning it owes more to creditors than it has in owned assets. While this doesn't mean the company is about to collapse, in the long-term, this is unsustainable. The company may have issues meeting financial obligations, is at risk of becoming insolvent and may have difficulty raising capital, especially more debt, if needed. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Negative equity (-CA$315k). Earnings have declined by 13% per year over the past 5 years. Market cap is less than US$10m (CA$1.40m market cap, or US$1.02m).
Reported Earnings • Aug 31Second quarter 2025 earnings released: CA$0.19 loss per share (vs CA$0.014 profit in 2Q 2024)Second quarter 2025 results: CA$0.19 loss per share (down from CA$0.014 profit in 2Q 2024). Revenue: CA$2.91m (down 58% from 2Q 2024). Net loss: CA$1.08m (down CA$1.16m from profit in 2Q 2024).
New Risk • Jun 02New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -CA$93k This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CA$93k free cash flow). Shares are highly illiquid. Earnings have declined by 3.4% per year over the past 5 years. Market cap is less than US$10m (CA$1.34m market cap, or US$978.9k).
Reported Earnings • Jun 02First quarter 2025 earnings released: CA$0.12 loss per share (vs CA$0.23 loss in 1Q 2024)First quarter 2025 results: CA$0.12 loss per share (improved from CA$0.23 loss in 1Q 2024). Revenue: CA$4.47m (down 32% from 1Q 2024). Net loss: CA$684.9k (loss narrowed 48% from 1Q 2024).
分析記事 • Mar 27Adastra Holdings Ltd. (CSE:XTRX) Soars 40% But It's A Story Of Risk Vs RewardDespite an already strong run, Adastra Holdings Ltd. ( CSE:XTRX ) shares have been powering on, with a gain of 40% in...
お知らせ • Feb 04Adastra Holdings Ltd. Announces Resignation of Andrew Hale as A Director, Effective February 14, 2025Adastra Holdings Ltd. announced that Andrew Hale has tendered his resignation as a director of the Company effective as of February 14, 2025. The Company thanks Mr. Hale for his service as a member of the board of directors. The remaining directors are in the process of identifying a candidate to fill the pending vacancy and will provide an update once available.
Reported Earnings • Dec 01Third quarter 2024 earnings released: EPS: CA$0.002 (vs CA$0.12 loss in 3Q 2023)Third quarter 2024 results: EPS: CA$0.002 (up from CA$0.12 loss in 3Q 2023). Revenue: CA$7.10m (up 63% from 3Q 2023). Net income: CA$84.5k (up CA$726.7k from 3Q 2023). Profit margin: 1.2% (up from net loss in 3Q 2023).
分析記事 • Oct 23Market Cool On Adastra Holdings Ltd.'s (CSE:XTRX) Revenues Pushing Shares 26% LowerThe Adastra Holdings Ltd. ( CSE:XTRX ) share price has fared very poorly over the last month, falling by a substantial...
お知らせ • Oct 18Adastra Holdings Ltd., Annual General Meeting, Dec 13, 2024Adastra Holdings Ltd., Annual General Meeting, Dec 13, 2024.
お知らせ • Sep 26+ 2 more updatesLachlan Mcleod Resigns as Chief Financial Officer of Adastra Holdings LtdAdastra Holdings Ltd. announced that Lachlan McLeod, Chief Financial Officer, has resigned from his role. Mr. McLeod's will remain in his roles as CFO until November 25, 2024, to ensure a smooth transition and maintain continuity as the Company moves forward. The Company is currently in the process of selecting and approving new candidates to fill these roles.
分析記事 • Sep 08Market Cool On Adastra Holdings Ltd.'s (CSE:XTRX) Revenues Pushing Shares 26% LowerTo the annoyance of some shareholders, Adastra Holdings Ltd. ( CSE:XTRX ) shares are down a considerable 26% in the...
分析記事 • Sep 04Is Adastra Holdings (CSE:XTRX) A Risky Investment?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Reported Earnings • Sep 01Second quarter 2024 earnings released: EPS: CA$0.001 (vs CA$0.019 loss in 2Q 2023)Second quarter 2024 results: EPS: CA$0.001 (up from CA$0.019 loss in 2Q 2023). Revenue: CA$6.87m (down 3.2% from 2Q 2023). Net income: CA$80.9k (up CA$1.15m from 2Q 2023). Profit margin: 1.2% (up from net loss in 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has fallen by 56% per year, which means it is performing significantly worse than earnings.
分析記事 • Jul 11Adastra Holdings Ltd. (CSE:XTRX) Might Not Be As Mispriced As It Looks After Plunging 41%Unfortunately for some shareholders, the Adastra Holdings Ltd. ( CSE:XTRX ) share price has dived 41% in the last...
Reported Earnings • Jun 04First quarter 2024 earnings released: CA$0.023 loss per share (vs CA$0.006 loss in 1Q 2023)First quarter 2024 results: CA$0.023 loss per share (further deteriorated from CA$0.006 loss in 1Q 2023). Revenue: CA$6.53m (up 13% from 1Q 2023). Net loss: CA$1.31m (loss widened 325% from 1Q 2023). Over the last 3 years on average, earnings per share has increased by 1% per year but the company’s share price has fallen by 42% per year, which means it is significantly lagging earnings.
分析記事 • May 08Adastra Holdings Ltd. (CSE:XTRX) Might Not Be As Mispriced As It Looks After Plunging 27%Adastra Holdings Ltd. ( CSE:XTRX ) shareholders won't be pleased to see that the share price has had a very rough...
お知らせ • May 03Adastra Holdings Files Form 15Adastra Holdings Ltd. has announced that it has filed a Form 15 with the Securities and Exchange Commission to voluntarily deregister its common shares under the Securities Exchange Act of 1934, as amended.
Reported Earnings • Apr 24Full year 2023 earnings released: CA$0.063 loss per share (vs CA$0.072 loss in FY 2022)Full year 2023 results: CA$0.063 loss per share (improved from CA$0.072 loss in FY 2022). Revenue: CA$22.2m (up 67% from FY 2022). Net loss: CA$3.54m (loss narrowed 17% from FY 2022). Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has fallen by 41% per year, which means it is significantly lagging earnings.
Board Change • Apr 19Less than half of directors are independentThere are 3 new directors who have joined the board in the last 3 years. Of these new board members, 1 was an independent director. The company's board is composed of: 3 new directors. No experienced directors. No highly experienced directors. 1 independent director (2 non-independent directors). Independent Director Paul Morgan is the most experienced director on the board, commencing their role in 2021. They were also the last independent director to join the board. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of experienced directors.
お知らせ • Apr 16+ 1 more updateAdastra Holdings Ltd. Announces Resignation of Smoke Wallin from Its Board of DirectorsAdastra Holdings Ltd. announced the resignation of Smoke Wallin from its Board of Directors, effective April 12, 2024. Mr. Wallin, who has served as a Director on Adastra's Board since May 2022, will be focusing on his other business ventures. The Company is now in the process of selecting a new Director to fill the Board vacancy.
お知らせ • Apr 03Adastra Holdings Announces Executive ChangesAdastra Holdings Ltd. announced the appointment of Jon Edwards to its Board of Directors, effective April 2, 2024. With over 15 years of experience, Mr. Edwards has held various positions within the B.C. Public Service, specializing in interpreting and applying legislation for the Ministry of Justice and Housing. He holds a Bachelor of Arts in Justice Studies and a Master of Arts in Conflict Analysis and Management, both from Royal Roads University. Mr. Edwards will use his extensive experience and commitment to excellence to positively impact the Company towards continued success. Mr. Edwards will be replacing Michael Forbes on Adastra's Board of Directors. On March 29, 2024, Mr. Forbes resigned as CEO, Director and Corporate Secretary, as previously announced in a news release dated March 1, 2024. Adastra also announces that Lachlan McLeod, the Company's CFO, has been appointed Corporate Secretary, effective April 2, 2024, while maintaining his current duties as CFO.
Board Change • Apr 01High number of new directorsDirector Andy Hale was the last director to join the board, commencing their role in 2024.
分析記事 • Mar 08Adastra Holdings Ltd.'s (CSE:XTRX) Shares Leap 26% Yet They're Still Not Telling The Full StoryAdastra Holdings Ltd. ( CSE:XTRX ) shareholders would be excited to see that the share price has had a great month...
分析記事 • Jan 23Adastra Holdings Ltd.'s (CSE:XTRX) Shares Not Telling The Full StoryWith a median price-to-sales (or "P/S") ratio of close to 1x in the Pharmaceuticals industry in Canada, you could be...
Reported Earnings • Dec 01Third quarter 2023 earnings released: CA$0.011 loss per share (vs CA$0.008 loss in 3Q 2022)Third quarter 2023 results: CA$0.011 loss per share (further deteriorated from CA$0.008 loss in 3Q 2022). Revenue: CA$4.35m (up 14% from 3Q 2022). Net loss: CA$642.2k (loss widened 40% from 3Q 2022). Over the last 3 years on average, earnings per share has increased by 43% per year but the company’s share price has fallen by 40% per year, which means it is significantly lagging earnings.
分析記事 • Sep 28Here's Why Adastra Holdings (CSE:XTRX) Can Afford Some DebtLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Reported Earnings • Aug 18Second quarter 2023 earnings released: CA$0.019 loss per share (vs CA$0.008 loss in 2Q 2022)Second quarter 2023 results: CA$0.019 loss per share (further deteriorated from CA$0.008 loss in 2Q 2022). Revenue: CA$7.10m (up 133% from 2Q 2022). Net loss: CA$1.07m (loss widened 124% from 2Q 2022). Over the last 3 years on average, earnings per share has increased by 51% per year but the company’s share price has fallen by 54% per year, which means it is significantly lagging earnings.
分析記事 • Aug 03Subdued Growth No Barrier To Adastra Holdings Ltd.'s (CSE:XTRX) PriceIt's not a stretch to say that Adastra Holdings Ltd.'s ( CSE:XTRX ) price-to-sales (or "P/S") ratio of 1.1x right now...
お知らせ • Jul 08Adastra Holdings Ltd., Annual General Meeting, Sep 14, 2023Adastra Holdings Ltd., Annual General Meeting, Sep 14, 2023. Location: 900 - 885 West Georgia Street Vancouver British Columbia Canada
Reported Earnings • May 03Full year 2022 earnings released: CA$0.072 loss per share (vs CA$0.055 loss in FY 2021)Full year 2022 results: CA$0.072 loss per share (further deteriorated from CA$0.055 loss in FY 2021). Revenue: CA$13.3m (up 136% from FY 2021). Net loss: CA$4.28m (loss widened 56% from FY 2021). Over the last 3 years on average, earnings per share has increased by 51% per year but the company’s share price has fallen by 23% per year, which means it is significantly lagging earnings.
お知らせ • Feb 15Adastra Holdings Ltd. Announces Executive ChangesAdastra Holdings Ltd. announced that Lachlan McLeod, CPA of Fehr & Associates, has been appointed Chief Financial Officer. Lachlan has experience in public practice, having worked as an auditor for a Big 4 accounting firm for four years, and has served as a fractional CFO for multiple public companies. Lachlan has a proven track record of helping businesses meet financial and regulatory reporting requirements. Lachlan is a Chartered Professional Accountant (CPA) with a Bachelor's degree in Science with an Economics major and a Business minor from the University of Victoria, and a Diploma of Accounting from the Sauder School of Business at the University of British Columbia. Lachlan replaces Oliver Foeste who will remain with Adastra in an advisory capacity to provide transitional support. The Company thanks Oliver for his services.
分析記事 • Jan 13Does Adastra Holdings (CSE:XTRX) Have A Healthy Balance Sheet?The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Reported Earnings • Dec 01Third quarter 2022 earnings released: CA$0.008 loss per share (vs CA$0.005 loss in 3Q 2021)Third quarter 2022 results: CA$0.008 loss per share (further deteriorated from CA$0.005 loss in 3Q 2021). Revenue: CA$3.80m (up 110% from 3Q 2021). Net loss: CA$459.3k (loss widened 121% from 3Q 2021).
Board Change • Nov 16High number of new and inexperienced directorsThere are 3 new directors who have joined the board in the last 3 years. The company's board is composed of: 3 new directors. No experienced directors. No highly experienced directors. President, CEO, Chairman & Company Secretary Michael Forbes is the most experienced director on the board, commencing their role in 2021. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model.
分析記事 • Sep 28We Think Adastra Holdings (CSE:XTRX) Has A Fair Chunk Of DebtHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
お知らせ • Sep 01Adastra Holdings Ltd. Receives Controlled Substances Dealer's LicenseAdastra Holdings Ltd. announce that the Company received its Controlled Drug and Substances Dealer's License on August 24, 2022. This license allows Adastra to process psilocybin and psilocin, the active compounds derived from psychedelic mushrooms. Under the Dealer's License, Adastra can possess up to 1,000 grams of psilocybin and psilocin at any time and can transfer the extracted material to other companies who hold a valid Dealer's License. Adastra intends to utilize its in-house analytical testing lab, Chemia Analytics, to validate and develop its extraction processes, to optimize and enhance efficiency ahead of any future potential regulatory modifications to the existing psychedelics framework. As the market matures to include regulations for other compounds, such as MDMA, LSD, 5-MeO-DMT and Ketamine, Adastra plans to include these substances in future Dealer's License amendments, positioning itself to leverage clinic and patient demand. When approved, the Company will be permitted to process and formulate a variety of psychedelic compounds, increasingly used and sought-after by patients and healthcare practitioners to combat a variety of physical and mental ailments.
Reported Earnings • Aug 27Second quarter 2022 earnings released: CA$0.008 loss per share (vs CA$0.012 loss in 2Q 2021)Second quarter 2022 results: CA$0.008 loss per share (up from CA$0.012 loss in 2Q 2021). Revenue: CA$3.05m (up 146% from 2Q 2021). Net loss: CA$478.1k (loss narrowed 6.2% from 2Q 2021).
お知らせ • Aug 18Adastra Holdings Ltd. Receives Its Medical Sales License from Health CanadaAdastra Holdings Ltd. announced it has received its Medical Sales License from Health Canada which now authorizes Adastra to sell cannabinoid-containing products that are formulated for and distributed to the medical cannabis market. With its Medical Sales License, Adastra is now authorized to: Sell cannabis extracts and dried cannabis to medical cannabis patients and licensed health practitioners; and Develop a broad range of products classified as cannabis extracts including: Inhaled, Ingested, and Other Adastra's Medical Sales License will enable the Company to maximize the full potential of PerceiveMD, Adastra's wholly-owned platform, that assesses patients seeking alternative treatments and remedies and provides documentation to enable access. The global medical cannabis market is projected to grow to $248.42 Billion by 2030 at a 31.97% CAGR according to a recent report by Market Research. Adastra expects to start producing medical format cannabis products, specifically CBD tinctures by January 2023. The Company is currently exploring medical distribution platforms for Canadian sales and plans toformulate products based on recommendations from practitioners and patients in its establishednetwork.
Board Change • Aug 03High number of new and inexperienced directorsThere are 3 new directors who have joined the board in the last 3 years. The company's board is composed of: 3 new directors. No experienced directors. No highly experienced directors. President, CEO, Chairman & Company Secretary Michael Forbes is the most experienced director on the board, commencing their role in 2021. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model.
お知らせ • May 17Adastra Holdings Ltd. Announces the Appointment of Smoke Wallin to the Company's Board of DirectorsAdastra Holdings Ltd. announced the appointment of Smoke Wallin to the Company's board of directors. Mr. Wallin is a highly accomplished CEO, entrepreneur, leader, board member and philanthropist with more than 25 years of success across the consumer products, beverage, cannabis, distribution and technology industries. He is a partner and Managing Director for STS Capital Partners; has frequently served as CEO for new and existing businesses.
お知らせ • May 04Adastra Holdings Ltd. announced delayed 20-F filingOn 05/03/2022, Adastra Holdings Ltd. announced that they will be unable to file their next 20-F by the deadline required by the SEC.
Board Change • Apr 27High number of new and inexperienced directorsThere are 3 new directors who have joined the board in the last 3 years. The company's board is composed of: 3 new directors. No experienced directors. No highly experienced directors. Independent Director Georges Routhier is the most experienced director on the board, commencing their role in 2019. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model.
お知らせ • Apr 22Adastra Holdings Ltd., Annual General Meeting, Jun 23, 2022Adastra Holdings Ltd., Annual General Meeting, Jun 23, 2022. Location: 5451 275 street Langley British Columbia Canada
お知らせ • Apr 08Adastra Announces Successful Soft Launch of Endgame Brand in BCAdastra Holdings Ltd. is excited to announce that its newly developed brand, Endgame, which was soft-launched last week, sold out in less than 24 hours of delivery to the British Columbia Liquor Distribution Branch. Endgame's initial SKU delivery included two varieties of vaporizer cartridges: Mosa x Blood Orange and White Rhino x Raspberry Lemon. In early April, Adastra plans to deliver two new Endgame shatter products to the BCLDB: BlackCherry Punch x Jack Herer and Jack Herer x White Rhino. These hydrocarbon extracted cannabis concentrates are gaining popularity in the Canadian cannabis market for their full spectrum extract potency and flavour.
お知らせ • Mar 30Adastra Holdings Ltd. Announces Executive ChangesAdastra Holdings Ltd. announced update to its leadership structure with the departure of Chief Operating Officer, Corporate Secretary and Director, Donald Dinsmore, and the appointment of Michael Forbes as Corporate Secretary.
分析記事 • Mar 23Does Adastra Holdings (CSE:XTRX) Have A Healthy Balance Sheet?The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
分析記事 • Dec 07Here's Why Adastra Holdings (CSE:XTRX) Can Afford Some DebtHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Board Change • Dec 06High number of new and inexperienced directorsThere are 4 new directors who have joined the board in the last 3 years. The company's board is composed of: 4 new directors. No experienced directors. No highly experienced directors. Independent Director Georges Routhier is the most experienced director on the board, commencing their role in 2019. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model.
Recent Insider Transactions • Sep 04President recently bought CA$1.1m worth of stockOn the 31st of August, Michael Forbes bought around 1m shares on-market at roughly CA$0.91 per share. This was the largest purchase by an insider in the last 3 months. This was Michael's only on-market trade for the last 12 months.
分析記事 • Aug 18Here's Why Phyto Extractions (CSE:XTRX) Can Afford Some DebtSome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
お知らせ • Jun 03Phyto Extractions Inc. Officially Launches Shatter for Adult-Use MarketPhyto Extractions Inc. strives to continuously bring consumers new and innovative products to enhance their experience and overall enjoyment. Shatter is Phyto ExtractionsTM newest product category, with three new high THC extract offerings produced from single- source strains (local to BC and ON). Available in three highly popular strains including: Blue Gorilla OG, Pink Kush and D Bubba, all Phyto ExtractionsTM shatter is extracted and processed in a controlled laboratory environment to prevent contaminants, living up to the brands promise of offering consumers products that are free of additives and synthetic fillers. In partnership with Namaste Technologies Inc. subsidiary, CannMart Inc., Phyto ExtractionsTM shatter is now available through licensed adult-use retailers in British Columbia, Saskatchewan and Manitoba. Strain availability currently varies in each provincial distributor and private store. Pink Kush and D Bubba have been selected in British Columbia. All three SKUs; Blue Gorilla OG, D Bubba and Pink Kush are available in Saskatchewan and Manitoba.
分析記事 • May 04Auditors Have Doubts About Phyto Extractions (CSE:XTRX)Unfortunately for shareholders, when Phyto Extractions Inc. ( CSE:XTRX ) reported results for the period to December...
お知らせ • Mar 25Adastra Labs Holdings Ltd. announced a financing transactionAdastra Labs Holdings Ltd. (CNSX:XTRX) announced a private placement on best effort basis of equity units at a price of CAD 1.10 per unit on March 23, 2021. The transaction will include participation from qualified investors, mainly accredited investors. Each unit consists of one common share and one warrant exercisable at CAD 1.75 per share for a period of 24 months from date of issuance. The warrants are subject to acceleration in the event the company’s common shares trade at or above CAD 2 per share for more than 50 trading days. The transaction will close in one or more tranches.
お知らせ • Mar 12+ 1 more updateAdastra Labs Holdings (2019) Ltd. Announces Executive ChangesAdastra Labs Holdings (2019) Ltd. announced the appointment of J. Scott Munro as CEO effective March 1, 2021 in conjunction with the resignation and retirement of Andy Hale from said positions. J. Scott Munro is an experienced venture capitalist, accountant and entrepreneur who has led companies and served in a variety of senior executive roles including CEO, CFO and director in both Canadian and U.S. public and private companies for over 25 years. Over the past 10+ years, Scott has owned and operated private venture capital and consulting firms that provide M&A advisory, going-public transactions, reporting, and other services to private and public companies, including in the Life Sciences sector in which Adastra operates.
Is New 90 Day High Low • Feb 03New 90-day low: CA$0.33The company is down 38% from its price of CA$0.53 on 04 November 2020. The Canadian market is up 14% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Pharmaceuticals industry, which is up 70% over the same period.
分析記事 • Dec 10Adastra Labs Holdings (CSE:XTRX) Is Making Moderate Use Of DebtThe external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Is New 90 Day High Low • Nov 17New 90-day low: CA$0.48The company is down 44% from its price of CA$0.86 on 19 August 2020. The Canadian market is up 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Pharmaceuticals industry, which is up 18% over the same period.
お知らせ • Nov 14Adastra Labs Holdings Ltd. Commences Full-Scale Cryo-Ethanol Extraction OperationsAdastra Labs Holdings Ltd. announced the full-scale operation of its cryo-ethanol extraction system from Evolved Extraction Solutions (Evolved). The Evolved team integrated with the Adastra production workforce to commission the EV-MASS system while leveraging remote support from the Yellowstone Falling Film Evaporator operations team. Both the EV-MASS cryo-ethanol system and the Yellowstone high-volume ethanol recovery system met all operational targets for the commissioning. The high quality cannabis oil has produced superior high potency cannabis THC distillate after follow-on processing with the company’s molecular wiped-film distillation systems. The EV-MASS cryo-ethanol system has commenced full operational capability after processing several hundred kilograms of cannabis biomass in a fraction of the time required by other extraction systems. The commissioning validated the ability of the system to process 650 KG of cannabis or hemp biomass per day, has made the company’s CO2 extraction line available for other concentrate products and reduced substantially the time required to produce cannabis oils and THC distillate. The industrial-scale EV-MASS system has become fully operation just in time to exploit the large processing demand the first outdoor Canadian cannabis harvest brings.
Is New 90 Day High Low • Oct 19New 90-day low: CA$0.67The company is down 14% from its price of CA$0.78 on 21 July 2020. The Canadian market is up 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Pharmaceuticals industry, which is up 7.0% over the same period.
お知らせ • Oct 04Adastra Labs Holdings Ltd. Announces the Completion of Installation and Start of Commissioning of its Cryo-Ethanol Extraction System from Evolved Extraction SolutionsAdastra Labs Holdings Ltd. announced the completion of installation and start of commissioning of its cryo-ethanol extraction system from Evolved Extraction Solutions ("Evolved"). The Evolved team provided equipment and installation services along with support from the Yellowstone Falling Film Evaporator OEM. The combination of the EV-MASS cryo-ethanol system with the high-volume ethanol recovery unit from Yellowstone substantially reduces the time to produce large volumes of cannabis oil ready for molecular distillation into high potency THC distillate. Commissioning and training services for the EV-MASS cryo-ethanol system has commenced with full operational capability planned in the coming weeks to ensure the EV-MASS system meets performance requirements. The cryo-ethanol extraction system is capable of processing 650 KG of cannabis or hemp biomass per day, producing winterized (de-waxed) cannabis or hemp oil. The EV-MASS integrated solution provides an optimized process flow that is expected to reduce the costs of production. The modular design permits Adastra to easily scale up capacity with simplified installation in the event of increased market demand. Further, the cryo-ethanol system frees up Adastra's CO2 extraction line for other types of concentrate products and will reduce the time required to produce cannabis oil as it comes online.
Is New 90 Day High Low • Sep 19New 90-day high: CA$0.98The company is up 206% from its price of CA$0.32 on 19 June 2020. The Canadian market is up 7.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Pharmaceuticals industry, which is up 3.0% over the same period.
お知らせ • Jul 17Adastra Labs Holdings Ltd. announced that it has received CAD 3.4944 million in fundingOn July 14, 2020, Adastra Labs Holdings Ltd. (CNSX:XTRX) closed the transaction. The company issued 11,648,001 units for gross proceeds of CAD 3,494,400.3. The company paid finders fees of CAD 21,600 in cash and 72,000 compensation options to Ascenta Finance Corp. in relation to the transaction. Each compensation warrant shall entitle the holder to purchase one unit for a period of 24 months from the closing of the transaction on the same terms as that of the warrants issued in the transaction. The transaction has been oversubscribed.
お知らせ • Jul 05Adastra Labs Holdings Ltd. to Report Second Half, 2020 Results on Jul 14, 2020Adastra Labs Holdings Ltd. announced that they will report second half, 2020 results on Jul 14, 2020
お知らせ • Jun 19+ 1 more updateAdastra Labs Holdings Ltd. announced that it expects to receive CAD 1 million in fundingAdastra Labs Holdings Ltd. (CNSX:XTRX) announced non-brokered private placement of up to 3,333,333 units at a price of CAD 0.30 per unit for gross proceeds of up to CAD 1,000,000 on June 18, 2020. Each unit consists of one common share and one common share purchase warrant exercisable at CAD 0.50 per share for a period of 24 months from issue. The warrants are subject to acceleration to the date that is 30 days after the date of notice of company if closing price exceeds CAD 0.70 per share for 10 consecutive trading days. The units to be issued will be subject to a four month and one day hold period. The company may close the transaction in one or more tranches. The company may pay commissions or finder fees. The company may make over allotments till CAD 2,000,000. The transaction is subject to applicable securities laws and regulatory approval.
